Search Results

You searched for : treatmentofHIV1

	ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptions ViiV Healthcare, today announced the positive findings of a pooled analysis of COVID-19-related impacts across the investigational long-acting cabotegravir and rilpivirine clinical ... Oct 21
	GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients GSK two drug combination is as good as 3 drug regimen which is presently continued for HIV 1 patients... Oct 09
	ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naÃ¯ve adults with HIV-1 Findings showed that the 2-drug regimen (2DR) of dolutegravir plus lamivudine continued to offer non-inferior efficacy... Oct 05
3 Matching result(s) found!

-Advertisements-

Trending Now
	10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
	Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
	Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
	Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
	Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
	Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
	Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
	Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
	Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
	Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
	American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
	Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
	Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
	From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
	World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
	Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
	Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
	Healthcare Startups to Watch Out for in 2025December 20, 2024
	Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
	The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024

Search Results

ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptions

GSK's Dovato holds against Tenofavir Alafenamide Fumarate for HIV1 patients

ViiV Healthcare announces dolutegravir plus lamivudine for treatment-naÃ¯ve adults with HIV-1

Trending Now